Carnitine-acylcarnitine translocase deficiency (CACT deficiency, OMIM # 212138) was first described by Stanley CA et al. in 1992 (1). This evidence concerns the gene SLC25A20 and hyperinsulinemic hypoglycemia, familial, 4.